Study of Feasibility and Safety of UCD19 Chimeric Antigen Receptor (CAR) T Cells in Adult Subjects With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (B-NHL)
Clinical trial NCT04240808 · COMPLETED
Trial details
- NCT number
- NCT04240808
- Sponsor
- University of Colorado, Denver
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-17
- Primary completion
- 2023-03-24
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.